Kidney Transplant; Complications
Conditions
Brief summary
There is an increasing number in patient's undergoing kidney transplantation in the United States. Furthermore, kidney recipients have high occurrence of 30-day readmissions that leads to high hospital costs and decreased quality of life for transplant recipients. A previous research finds that high levels of post-transplant anxiety is correlated with increased likelihood of 30-day readmissions. The goal of this study is to design and implementat a randomized control trial (RCT) using a standardized post-transplant mentoring program in order to reduce 30-day readmission and post-transplant anxiety among recipients.
Detailed description
In this research, the investigators will seek to examine the efficacy of using former patients as mentors to newly transplanted patients and its relationship with patient anxiety following discharge as well as the prevention of 30-day readmissions for kidney transplant recipients. The primary hypothesis is that the treatment group of patients who undergo a targeted mentorship program will be better compliant with the discharge instructions and will perform better when compared to the control group who undergoes current routine post-transplantation care. Evidence from this experiment can help advance our understanding of patient-engagement in the continuity of care delivery, decrease patient readmission rates, and improve overall cost utilization. Methods: The investigators will conduct a single institution randomized control trial assigning patients getting discharged after a kidney transplant to a treatment group that involves a 30-day mentoring initiative by former transplant patients, and comparing the efficacy with a similar control group. The overall study period will be divided into the following sections, summarized in Figure 1.
Interventions
Phone Conversations on the importance of complying to discharge instructions delivered before discharge
Sponsors
Study design
Intervention model description
A single institution randomized control trial assigning patients getting discharged after a kidney transplant to treatment and control group
Eligibility
Inclusion criteria
* any patient who received a kidney transplantation, deceased or living donor, during the study period.
Exclusion criteria
* anyone younger than 18 years old or older than 70 years old.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 30-day readmissions | 30-days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Post Transplant Anxiety | 1 Day of Discharge and 30-days after discharge | State-Trait Anxiety Inventory (STAI) for Adults |
| Preventable Re-admissions | 30-days after day of discharge | Re admissions due to missed labs or medications as measured by time of readmission for any readmission that was deemed preventable by physiologic laboratory data, reason for readmission, and primary complaint determined by trained kidney transplantation nurses |
Countries
United States